{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-203746","form_type":"8-K","ticker":"BDSX","cik":"0001439725","company_name":"BIODESIX INC","filed_at":"2025-09-15T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.001612+00:00","generated_at":"2026-05-17T06:36:50.161925+00:00","sec_items":["3.03","5.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Biodesix effects 1-for-20 reverse stock split, eliminates Series A preferred","bullets":["Reverse stock split at 1:20 ratio effective Sep 15, 2025; new CUSIP 09075X207.","No fractional shares issued; cash-in-lieu based on closing price before effective date.","Certificate of Elimination for Series A Non-Voting Convertible Preferred filed Sep 12, 2025.","Stockholder approval obtained May 20, 2025; Board set final ratio on Sep 4, 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-203746","json":"https://secwatch.observer/filing/0001193125-25-203746.json","markdown":"https://secwatch.observer/filing/0001193125-25-203746.md","text":"https://secwatch.observer/filing/0001193125-25-203746.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1439725/000119312525203746/0001193125-25-203746-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1439725/000119312525203746/d14130d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T06:36:50.161925+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4b5e23d908ffb33f79ec43ccee7d19378bcfc88f","claim":"BIODESIX INC: Filed a Certificate of Elimination to remove provisions related to Series A Non-Voting Convertible Preferred Stock (effective 2025-09-12).","evidence_excerpt":"On September 12, 2025, Company filed a Certificate of Elimination of the Series A Non-Voting Convertible Preferred Stock (the “Certificate of Elimination”) with the Delaware Secretary of State effecting the elimination of all provisions of the Certificate of Designations previously filed by the Company with the Delaware Secretary of State on April 8, 2024 related to a series of preferred stock designated as Series A Non-Voting Convertible Preferred Stock.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1439725/000119312525203746/0001193125-25-203746-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2025-09-12"}],"fact_type":"governance_change"},{"claim_id":"6f95472e3a710cad994e2d7127eef6ef1689756e","claim":"BIODESIX INC: Effected a one-for-twenty reverse stock split via amendment to the charter (effective 2025-09-15).","evidence_excerpt":"Following such approval, the Company filed an amendment to its Charter (the “Reverse Split Amendment”) with the Secretary of State of the State of Delaware (the “Delaware Secretary of State”) to effect the Reverse Stock Split, with an effective time of 12:01 a.m. Eastern Time on September 15, 2025.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1439725/000119312525203746/0001193125-25-203746-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2025-09-15"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}